{"product_id":"human-tnfsf11-rankl-tumor-necrosis-factor-ligand-superfamily-member-11-elisa-kit-eh0313","title":"Human TNFSF11\/RANKL(Tumor necrosis factor ligand superfamily member 11) ELISA Kit","description":"\u003cp\u003eRANKL|TNFSF11|CD254|ODF|OPGL|RANK L|TNFSF11|CD254 antigen|OPGLOPTB2|TRANCEODFhRANKL2\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHuman TNFSF11\/RANKL(Tumor necrosis factor ligand superfamily member 11) ELISA Kit\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAlias\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eTumor necrosis factor ligand superfamily member 11 ELISA Kit\u003c\/em\u003e, \u003cem\u003eOsteoclast differentiation factor (ODF) ELISA Kit\u003c\/em\u003e, \u003cem\u003eOsteoprotegerin ligand (OPGL) ELISA Kit\u003c\/em\u003e, \u003cem\u003eReceptor activator of nuclear factor kappa-B ligand (RANKL) ELISA Kit\u003c\/em\u003e, \u003cem\u003eTNF-related activation-induced cytokine (TRANCE) ELISA Kit\u003c\/em\u003e, \u003cem\u003eCD254 ELISA Kit\u003c\/em\u003e, \u003cem\u003eTNFSF11 ELISA Kit\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetection Method\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSandwich ELISA, Double Antibody\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eApplication\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.fn-test.com\/?post_type=product\u0026amp;s=TNFSF11\/RANKL\"\u003eTNFSF11\/RANKL ELISA Kit\u003c\/a\u003e allows for the in vitro quantitative determination of TNFSF11\/RANKL concentrations in serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSize\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e96T\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRange\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e15.625-1000pg\/ml\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSensitivity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u0026lt; 9.375pg\/ml\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHuman\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUniProt ID\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.uniprot.org\/uniprot\/O14788\"\u003eO14788\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStandard Curve\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/www.fn-test.com\/content\/uploads\/product\/images\/elisa\/standard-curve\/EH0313-CM.jpg\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e2-8 ℃ for 6 months\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMatrices listed below were spiked with certain level of TNFSF11\/RANKL and the recovery rates were calculated by comparing the measured value to the expected amount of TNFSF11\/RANKL in samples.\u003c\/p\u003e\n\u003ctable width=\"491\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003eMatrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery range(%)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003eAverage(%)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eserum(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e86-101\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e93\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eEDTA plasma(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e93-105\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e98\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eheparin plasma(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e87-104\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e97\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eLinearity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe linearity of the kit was assayed by testing samples spiked with appropriate concentration of TNFSF11\/RANKL and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.\u003c\/p\u003e\n\u003ctable width=\"491\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003eSample\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003e1:2\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003e1:4\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003cstrong\u003e1:8\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eserum(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e85-104%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e91-105%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e87-99%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eEDTA plasma(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e83-99%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e84-101%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e82-101%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eheparin plasma(n=5)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e82-99%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e88-100%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e85-97%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCV(%)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIntra-Assay: CV\u0026lt;8%\u003cbr\u003e Inter-Assay: CV\u0026lt;10%\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNote\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor Research Use Only\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"FineTest","offers":[{"title":"96T \/ 46.875pg\/ml \/ 78.125-5000pg\/ml","offer_id":42522653622496,"sku":"EH0313","price":450.0,"currency_code":"KRW","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0601\/9330\/8896\/products\/EM2109_9d287f18-b9c3-4c74-a550-a15539ed60f0.jpg?v=1690496367","url":"https:\/\/rndmate.com\/products\/human-tnfsf11-rankl-tumor-necrosis-factor-ligand-superfamily-member-11-elisa-kit-eh0313","provider":"알앤디메이트","version":"1.0","type":"link"}